Table 1. . Patient demographics.
| Clinical characteristics | Variable | n (all 56 pts) | % of pts |
|---|---|---|---|
| Gender | Male | 37 | 66 |
| Stage | IV (pleural effusion only) | 4 | 7 |
| IV | 52 | 93 | |
| Histopathological subtype | Adenocarcinoma | 38 | 68 |
| Large-cell carcinoma | 18 | 32 | |
| Performance status | ECOG PS 0 | 9 | 16 |
| ECOG PS 1 | 26 | 46 | |
| ECOG PS 2 | 21 | 38 | |
| Site of MTS† (n = all stage IV pts with distant metastases) | Lung | 30 | 58 |
| Liver | 8 | 15 | |
| Adrenal gland | 13 | 25 | |
| Bone | 7 | 13 | |
| Distant lymph nodes | 23 | 44 | |
| Brain | 7 | 14 | |
| Other | 2 | 4 | |
†21 pts had more than one site of metastatic disease.
MTS: Metastases; Pts: Patients.